Skip to content

The Effect of Pelvic Floor Muscle Exercises on the Inferior Vena Cava

Investigation of Acute Effect of Pelvic Floor Muscle Exercises on Inferior Vena Cava

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05654324
Enrollment
51
Registered
2022-12-16
Start date
2023-05-01
Completion date
2023-10-02
Last updated
2023-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supine Hypotensive Syndrome

Brief summary

The aim of this study is to examine the effect of pelvic floor muscle exercises on the hemodynamic responses of the vena cava inferior in pregnant and non-pregnant women.

Detailed description

The IVC is responsible for approximately two-thirds of the total venous return to the heart. The blood flow in the IVC is affected by the respiratory and cardiac cycle. One of the factors affecting blood flow is pregnancy. Studies have shown that the hemodynamic responses of the IVC may vary depending on the position, and that the supine position puts pressure on the IVC during pregnancy. Compression of the growing fetus against the IVC can cause supine hypotensive syndrome and fetal danger. However, there is no definite finding about the effects of exercise performed in the supine position. Jefferys et al. reported that the reduction in blood flow at rest is twice that that occurs during exercise and that the level of blood flow should not be a cause for concern in healthy asymptomatic women who choose to exercise in the supine position in late pregnancy. Based on this information, we predict that pelvic floor muscle exercises can change the hemodynamic responses of the IVC and reduce the compression on it. In order to evaluate the effect of pelvic floor muscle exercises on hemodynamic responses of IVC and compression on it, pregnant and non-pregnant women will be measured by ultrasonography. Women eligible for the study will be seated and rested for 30 minutes before taking the measurement. Then, he will be taken to the supine position, rested for 2 minutes, and the first measurements will be taken at the 3rd minute. pelvic floor muscle exercises will be applied for 5 minutes as stated in the literature. Ultrasonographic measurements will be repeated in the supine position immediately after the pelvic floor exercises and 5 minutes after the exercise. Measurements will be applied to all participants in the same order. During the exercises blood pressure, heart rate and peripheral oxygen saturation will be monitored. Before and after the exercises, the heart rate and blood pressure parameters of the women will be recorded.

Interventions

Before the pelvic floor exercises are taught to all women participating in the study, a brief informational training about the function and structure of the pelvic floor and pelvis will be given using visuals. The application protocol will be given by experienced specialist physiotherapists who have received special training on pelvic floor muscle training. In this study, the training protocol described by Mørkved et al and Bø et al will be used. An exercise series will consist of slow and fast muscle contractions of the pelvic floor muscles. The exercise series will include 10 reps of maximum pelvic floor muscle contraction held for 6 seconds followed by three rapid muscle contractions. A 10-second rest period will be given between each exercise series. A total of 5 minutes, 4 repetitions of pelvic floor muscle contraction series will be applied, including the rest period.

Sponsors

Izmir University of Economics
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Double (Participant, Outcomes Assessor)

Intervention model description

This research is a prospective and controlled study. The data of the study will be collected from pregnant women (Experimental group) and non-pregnant women (Control group).

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

Experimental group * Being pregnant between the ages of 18-40, * At least primary school graduate and able to read and write, * The gestational age is 20-40 weeks, * Not having any mental problems that prevent cooperation and understanding. Control group * Being a non-pregnant woman who is in the same age range as the experimental group, * At least primary school graduate and able to read and write, * Not having any mental problems that prevent cooperation and understanding.

Exclusion criteria

* Pregnant women with acute or chronic diseases with poor placental adaptation and vascular damage such as diabetes, chronic arterial hypertension and preeclampsia, as the fetus is closer to the threshold of hypoxia and acidemia and adaptive phenomena may fail, * Pregnant women with intra-uterine growth restriction and fetal anomaly, * Pregnant women with cardiovascular disease, * Pregnant women considered as high risk by the obstetrician, * Pregnant women with premature, premature birth or miscarriage risk, * Pregnant women diagnosed with neurological disease, * Obese women (body mass index \> 30), * Women whose IVC measurements cannot be made with ultrasonography, * Women with severe low back pain (not able to do housework regularly), * Women who have been diagnosed with a psychiatric illness, * Women with a history of gynecological surgery, * Women with pelvic floor dysfunction, * Women who cannot lie in the supine position.

Design outcomes

Primary

MeasureTime frameDescription
Change of the collapsibility index (%) of IVCimmediately after the interventionThe collapsibility index (%) of IVC will be calculated using the formula: \[(Maximum IVC diameter - Minimum IVC diameter)/Maximum IVC diameter\] × 100.
Change of Pulsatility index of IVCimmediately after the interventionDoppler (Toshiba Medical Systems, Aplio 400, Berlin) flow velocimetry will be evaluated.
Changes of IVC diametersimmediately after the interventionM mode ultrasonography will be used for expiratory (IVC d min) and end-inspiratory (IVC d min) diameter measurement.

Secondary

MeasureTime frameDescription
Change of the collapsibility index (%) of IVC5 minutes after the interventionThe collapsibility index (%) of IVC will be calculated using the formula: \[(Maximum IVC diameter - Minimum IVC diameter)/Maximum IVC diameter\] × 100.
Change of Pulsatility index of IVC5 minutes after the interventionDoppler (Toshiba Medical Systems, Aplio 400, Berlin) flow velocimetry will be evaluated.
Changes of IVC diameters5 minutes after the interventionM mode ultrasonography will be used for expiratory (IVC d min) and end-inspiratory (IVC d min) diameter measurement.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026